Member Bibliography/Bibliografía de Miembros
This page collects all the personal publications that CienciaPR members have uploaded to their profiles. You can also see all of the authors collected in these publications or all the keywords contained in these publications.
“Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects.”, Antivir Ther, vol. 17, no. 3, pp. 557-63, 2012.
“Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.”, Pediatr Infect Dis J, vol. 30, no. 10, pp. 877-82, 2011.
“Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.”, J Virol, vol. 84, no. 6, pp. 2762-73, 2010.
“Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.”, AIDS Res Hum Retroviruses, vol. 26, no. 10, pp. 1047-9, 2010.
“Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.”, AIDS, vol. 23, no. 3, pp. 369-75, 2009.
“HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.”, AIDS Res Hum Retroviruses, vol. 24, no. 9, pp. 1203-8, 2008.
“Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption ”, AIDS, vol. 22, no. 10, pp. 1153-61, 2008.
“HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.”, J Clin Immunol, vol. 26, no. 1, pp. 40-54, 2006.
“Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.”, PLoS Med, vol. 1, no. 3, p. e64, 2004.
“Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.”, AIDS, vol. 17, no. 16, pp. 2337-43, 2003.
“Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.”, J Infect Dis, vol. 188, no. 6, pp. 873-82, 2003.